If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...

Gene editing company ToolGen “seeks fair licensing agreement” for alleged infringement by rival | High-value sickle cell ...

The firm hired Brent Babcock as a partner in New York, bringing experience in cases involving biotechnology and medical ...

10 April 2025 Decision overturns earlier decision allowing generic drug maker to launch version | Dispute centres on ...

Prompter patent issue will provide earlier protection for inventions and could avoid need for Quick Path Information ...

Massachusetts lawsuit claims subsidiary of UK pharma company unlawfully re-patented eculizumab, resulting in overpayments of ...

Texas company launches sweeping lawsuits against five major players, alleging infringement of medical device patents tied to ...

AstraZeneca fends off diabetes generic, for now ...

Pharma giant dodges threat as US judge dismisses monopoly claims over its blockbuster cancer drug | FDA approves new ...

The Düsseldorf court’s decision offers an instructive perspective on the legal nature of patent pledges as well as a reminder ...

Firm’s chair says Fenwick has been active in market for a long time and “waiting to find the right opportunity to deepen our bench and presence”.

A new High Court judge will be tasked with the “massive decision” on the plausibility of Bristol Myers Squibb’s key anticoagulant patent, following its appeal over failures in the previous trial, say ...